Spectra Systems Stock (OTC:SCTQ), Trade Ideas

Spectra Systems Corp invents, develops, manufactures, and markets technology-based products used to authenticate and process banknotes and also offers secure software products for gaming. The company has divided its business into Authentication Systems, Banknote cleaning technology, and Secure transactions.

Spectra Systems Corp

Macro Economic Events

News

Politics

Economics

General

iShares MSCI Turkey Investable Market Index Fund

Turkish Foreign Ministry Spokesperson Says "Our President's Visit To The U.S. Postponed To A Later Date Convenient To Both Sides Due To Scheduling Conflicts"; "High-Level Dialogue Between Turkey And The U.S. Will Continue"

<p>In what will be a landmark move in sports media history, the <a href="https://theathletic.com/nba/">NBA</a> and Amazon Prime Video have the framework of a deal that will make the streaming service one of the main homes for the league games, executives with direct knowledge of the talks told <i>The Athletic</i>.</p>
<p>It is expected that Prime Video's package will include significant regular season and postseason games, perhaps even some conference finals. The anticipation is that the final contract will be for at least a decade and begin the 2025-2026 season.</p>
<p>ESPN/ABC, as the website Puck reported Thursday, also has a framework of a deal with the expectations that an agreement will be completed. ESPN/ABC are expected to keep the Finals on its networks for the duration of its deals. Like Amazon, ESPN's new contract is also expected to be at least a decade in length.</p>
<p>&nbsp;</p>
<p>All of the details are not finalized yet, but all sides are under the expectations they will get done. The NBA, Amazon and ESPN all declined to comment.</p>
<p>The NBA prefers to have three companies involved in its new deals, but has not ruled out adding a fourth.</p>
<p>The NBA is finishing up nine-year deals that pay it $2.6 billion on average from ESPN and TNT Sports. Those contracts end after the 2024-2025 season.</p>
<p>The advancement in the Amazon and ESPN talks leaves incumbent Warner Bros. Discovery, which owns network TNT Sports, to face off with NBC, owned by Comcast, for the likely last package of games. Warner Bros. Discovery has the right to match deals, but NBC could try to structure an agreement in a way that makes it difficult.</p>
<p>While there is still work to be completed for the final arrangements, the current packages are going to be pruned slightly to create the third partner. In one arrangement, ESPN will cut down from around 100 games to around 80, according to executives briefed on the talks.</p>
<p>A natural landing spot for Amazon's regular-season games could be Thursday night, where it already has the <a href="https://theathletic.com/nfl/">NFL</a> from September to early January. The NBA, in recent years, has moved its games off Thursday during the time period to not go head-to-head with the NFL. It is expected to then have significant playoff inventory. Amazon has shown interest in global rights, which has been a key part of the NBA's negotiating strategy as it lined all of its domestic and international deals to end following the 2024-2025 season</p>
<p>The NBA has made it clear that it wanted to define itself for the next frontier of viewing with streaming at the forefront.</p>
<p>With ESPN, Amazon and the NBA all under the impression that they will complete deals, this puts the onus on TNT Sports, which has had the NBA since 1984. It is in a fight with NBC, which was the lead partner of the NBA before losing its rights in 2002. NBC, with its streaming service, Peacock, wants back in and is competing with Warner Bros. Discovery Sports for a deal.</p>
<h2>&nbsp;</h2>
<p><br />&nbsp;</p>


AMZN

CMCSA

'Amazon Prime Acquires NBA Broadcast Rights, Per Sources, Putting Pressure On TNT, NBC' - The Athletic

WIIM

BURL

Shares of retail stocks are trading higher amid overall market strength.

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Hershey</strong>.</p>
<p>Looking at options history for Hershey (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>) we detected 9 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 11% of the investors opened trades with bullish expectations and 88% with bearish.</p>
<p>From the overall spotted trades, 7 are puts, for a total amount of $545,613 and 2, calls, for a total amount of $65,985.</p>
<h3>Projected Price Targets</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $187.5 to $210.0 for Hershey during the past quarter. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Hershey's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Hershey's whale activity within a strike price range from $187.5 to $210.0 in the last 30 days. </p>
<h3>Hershey Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714160783_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>HSY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$23.8</td>
<td>$23.6</td>
<td>$23.8</td>
<td>$210.00</td>
<td>$238.0K</td>
<td>109</td>
<td style="text-align: right;">100</td>
</tr>
<tr>
<td>HSY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$24.1</td>
<td>$23.9</td>
<td>$24.1</td>
<td>$210.00</td>
<td>$72.3K</td>
<td>109</td>
<td style="text-align: right;">240</td>
</tr>
<tr>
<td>HSY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$23.9</td>
<td>$23.8</td>
<td>$23.9</td>
<td>$210.00</td>
<td>$71.7K</td>
<td>109</td>
<td style="text-align: right;">160</td>
</tr>
<tr>
<td>HSY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$15.6</td>
<td>$15.5</td>
<td>$15.6</td>
<td>$200.00</td>
<td>$62.4K</td>
<td>196</td>
<td style="text-align: right;">40</td>
</tr>
<tr>
<td>HSY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$2.7</td>
<td>$2.6</td>
<td>$2.65</td>
<td>$195.00</td>
<td>$36.3K</td>
<td>2.2K</td>
<td style="text-align: right;">100</td>
</tr>
</tbody>
</table>
</p>
<h3>About Hershey</h3>
<p>Hershey is a leading confectionery manufacturer in the us (around a $25 billion market), controlling around 36% of the domestic chocolate space (per Euromonitor). Beyond its namesake label, the firm's mix has expanded over the last 85 years and now consists of 100 brands, including Reese's, Kit Kat, Kisses, and Ice Breakers. Hershey's products are sold in about 80 countries, albeit with just a high-single-digit percentage of sales coming from markets outside the us, including Brazil, India, and Mexico. The firm has sought inorganic opportunities to extend its reach beyond its core confection business, adding Amplify Snack Brands and its Skinny Pop ready-to-eat popcorn to its mix, Pirate Brands, and Dot's Pretzels over the past few years.</p>
<p>After a thorough review of the options trading surrounding Hershey, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Where Is Hershey Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 769,418, the HSY's price is down by -0.3%, now at $186.59. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 7 days.</li>
</ul>
<h3>Professional Analyst Ratings for Hershey</h3>
<p>A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $192.66666666666666.</p>
<ul>
<li>Maintaining their stance, an analyst from Wells Fargo continues to hold a Equal-Weight rating for Hershey, targeting a price of $200. </li>
<li>An analyst from Piper Sandler persists with their Neutral rating on Hershey, maintaining a target price of $179. </li>
<li>Maintaining their stance, an analyst from Citigroup continues to hold a Neutral rating for Hershey, targeting a price of $199. </li>
</ul>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Hershey, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

Check Out What Whales Are Doing With HSY

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Recursion Pharmaceuticals</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXRX#NASDAQ">RXRX</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with RXRX, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 15 uncommon options trades for Recursion Pharmaceuticals.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 60% bullish and 40%, bearish.</p>
<p>Out of all of the special options we uncovered, 7 are puts, for a total amount of $261,224, and 8 are calls, for a total amount of $327,927.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $7.5 to $10.0 for Recursion Pharmaceuticals over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Recursion Pharmaceuticals's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Recursion Pharmaceuticals's significant trades, within a strike price range of $7.5 to $10.0, over the past month.</p>
<h3>Recursion Pharmaceuticals Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714160778_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>RXRX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$2.1</td>
<td>$2.0</td>
<td>$2.1</td>
<td>$9.00</td>
<td>$56.9K</td>
<td>1</td>
<td style="text-align: right;">919</td>
</tr>
<tr>
<td>RXRX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$2.1</td>
<td>$2.0</td>
<td>$2.09</td>
<td>$9.00</td>
<td>$56.8K</td>
<td>1</td>
<td style="text-align: right;">646</td>
</tr>
<tr>
<td>RXRX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$1.85</td>
<td>$1.75</td>
<td>$1.85</td>
<td>$7.50</td>
<td>$50.3K</td>
<td>1.2K</td>
<td style="text-align: right;">719</td>
</tr>
<tr>
<td>RXRX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$1.85</td>
<td>$1.75</td>
<td>$1.85</td>
<td>$7.50</td>
<td>$50.0K</td>
<td>1.2K</td>
<td style="text-align: right;">446</td>
</tr>
<tr>
<td>RXRX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$2.15</td>
<td>$2.0</td>
<td>$2.15</td>
<td>$9.00</td>
<td>$43.0K</td>
<td>1</td>
<td style="text-align: right;">200</td>
</tr>
</tbody>
</table>
</p>
<h3>About Recursion Pharmaceuticals</h3>
<p>Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.</p>
<p>After a thorough review of the options trading surrounding Recursion Pharmaceuticals, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Where Is Recursion Pharmaceuticals Standing Right Now?</h3>
<ul>
<li>With a trading volume of 2,960,648, the price of RXRX is up by 0.13%, reaching $7.85.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 14 days from now.</li>
</ul>
<h3>Expert Opinions on Recursion Pharmaceuticals</h3>
<p>In the last month, 1 experts released ratings on this stock with an average target price of $17.0.</p>
<ul>
<li>An analyst from Needham has revised its rating downward to Buy, adjusting the price target to $17. </li>
</ul>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Recursion Pharmaceuticals options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


RXRX

Recursion Pharmaceuticals's Options Frenzy: What You Need to Know

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>McDonald's</strong>.</p>
<p>Looking at options history for McDonald's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCD#NYSE">MCD</a>) we detected 10 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 30% with bearish.</p>
<p>From the overall spotted trades, 2 are puts, for a total amount of $111,612 and 8, calls, for a total amount of $344,592.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $140.0 and $370.0 for McDonald's, spanning the last three months.</p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for McDonald's's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of McDonald's's whale trades within a strike price range from $140.0 to $370.0 in the last 30 days. </p>
<h3>McDonald's 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714160773_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MCD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$1.6</td>
<td>$1.5</td>
<td>$1.6</td>
<td>$285.00</td>
<td>$76.3K</td>
<td>1.9K</td>
<td style="text-align: right;">543</td>
</tr>
<tr>
<td>MCD</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$18.6</td>
<td>$17.75</td>
<td>$18.25</td>
<td>$275.00</td>
<td>$73.0K</td>
<td>101</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>MCD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$138.5</td>
<td>$134.3</td>
<td>$136.0</td>
<td>$140.00</td>
<td>$68.0K</td>
<td>8</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>MCD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$9.15</td>
<td>$9.15</td>
<td>$9.15</td>
<td>$270.00</td>
<td>$41.1K</td>
<td>1.4K</td>
<td style="text-align: right;">51</td>
</tr>
<tr>
<td>MCD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$2.96</td>
<td>$2.75</td>
<td>$2.75</td>
<td>$270.00</td>
<td>$38.6K</td>
<td>663</td>
<td style="text-align: right;">39</td>
</tr>
</tbody>
</table>
</p>
<h3>About McDonald's</h3>
<p>McDonald's is the largest restaurant owner-operator in the world, with 2023 system sales of $130 billion across nearly than 42,000 stores and 115 markets. McDonald's pioneered the franchise model, building its footprint through partnerships with independent restaurant franchisees and master franchise partners around the globe. The firm earns roughly 60% of its revenue from franchise royalty fees and lease payments, with most of the remainder coming from company-operated stores across its three core segments: the United States, internationally operated markets, and international developmental/licensed markets.</p>
<p>In light of the recent options history for McDonald's, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Where Is McDonald's Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 2,520,286, with MCD's price down by -1.76%, positioned at $270.75.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 4 days.</li>
</ul>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest McDonald's options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Looking At McDonald's's Recent Unusual Options Activity

American Airlines Says As A Result Of Ongoing Boeing 787 Delivery Delays, Adjusting Service On Certain Routes In H2 Of 2024 & Q1 2025

Western Digital shares are trading higher following Q3 earnings. Benchmark upgraded the stock from Hold to Buy while multiple analysts also raised their price targets on the stock.

Management

GOOG

GOOGL

SNAP

TikTok General Counsel Erich Andersen Will Step Down In June To Take Role Of Special Counsel To Company

<p><strong>Microsoft Corp </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), <strong>Alphabet Inc </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>), and <strong>Meta Platforms Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) have each made significant strides in cloud capital expenditure (capex) and <a href="https://www.benzinga.com/topic/artificial-intelligence">artificial intelligence (AI) investments</a>.</p>
<p>According to a JPMorgan research <a href="https://markets.jpmorgan.com/research/email/scx/-nka2cu4/M4YCOaXxRlzdNFK2dZZFvQ/GPS-4685179-0">report</a>, these actions bode well for AI-levered cloud service provider (CSP) companies:  <strong>Arista Networks Inc </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NASDAQ">ANET</a>), <strong>Coherent Corp</strong> (COHR), <strong>Dell Technologies Inc </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) and <strong>Lumentum Holdings Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>). </p>
<p>The firm noted that alternative AI beneficiary picks include <strong>Flex Ltd.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLEX#NASDAQ">FLEX</a>) and <strong>Jabil Inc</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>).</p>
<p><em>Also Read: <a href="https://www.benzinga.com/news/earnings/24/04/38461410/meta-actually-has-major-profit-margins-unlike-tesla-redditor-reacts-to-stock-drop-following-q1-earn">&#8216;Meta Actually Has Major Profit Margins Unlike Tesla&#8217;: Redditor Reacts To Stock Drop Following Q1 Earnings</a></em></p>
<p>Both Microsoft and Alphabet have reported substantial increases in their cloud capex, exceeding market expectations and focusing on expanding AI infrastructure. </p>
<p>The aggregate capex for both companies is more than 20% above consensus estimates, indicating a strong commitment to AI investment.</p>
<p>JPMorgan has reiterated its preference for AI-levered names, including Arista, Coherent, Dell, Lumentum, Flex and Jabil. These companies are expected to benefit from the increased investments in AI infrastructure by the top cloud service providers (CSPs).</p>
<p>And Microsoft, Alphabet, and Meta are expected to lead to a strong year for data center capex. </p>
<p>Industry growth forecasts for data center investments from the top CSPs are now tracking in the mid-teens range for 2024, up from previous expectations of around 10%. </p>
<p>This growth is expected to outpace the increase seen in 2023, although it will still be below the levels seen in 2022.</p>
<h3 class="wp-block-heading"><strong>Bullish On AI Beneficiaries</strong></h3>
<p>The focus on AI infrastructure by these tech giants is seen as a positive sign for the AI sector as a whole. It should lead to significant gains for AI-levered stocks in the coming year.</p>
<p>Investors in artificial intelligence-focused ETFs such as the <strong>Global X Robotics &amp; Artificial Intelligence ETF </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOTZ#NYSE">BOTZ</a>), the <strong>Global X Artificial Intelligence &amp; Technology ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIQ#NYSE">AIQ</a>) and the <strong>ROBO Global Robotics</strong> <strong>&amp; Automation Index ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROBO#NYSE">ROBO</a>) should also see greener days ahead.</p>
<p><em>Read Next: <a href="https://www.benzinga.com/news/earnings/24/04/38459367/google-copy-pasted-what-meta-did-last-quarter-redditor-on-q1-earnings">Google &#8216;Copy Pasted What META Did Last Quarter,&#8217; Redditor On Q1 Earnings</a></em></p>


Earnings

Long Ideas

Specialty ETFs

Tech

Trading Ideas

ETFs

ANET

BOTZ

COHR

DELL

FLEX

MSFT

ROBO

Microsoft, Alphabet And Meta's Raised AI Capex Outlook Could Benefit These JPMorgan Stock Picks

Macro Notification

Benzinga Closing Bell Update: Tech Gains On Microsoft And Alphabet Earnings, Semis Gain, Dollar Rises

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Carnival</strong>.</p>
<p>Looking at options history for Carnival (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) we detected 17 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 23% of the investors opened trades with bullish expectations and 70% with bearish.</p>
<p>From the overall spotted trades, 3 are puts, for a total amount of $112,041 and 14, calls, for a total amount of $468,479.</p>
<h3>Projected Price Targets</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $13.0 to $20.0 for Carnival over the last 3 months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In terms of liquidity and interest, the mean open interest for Carnival options trades today is 13970.25 with a total volume of 29,536.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Carnival's big money trades within a strike price range of $13.0 to $20.0 over the last 30 days.</p>
<h3>Carnival Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714159894_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CCL</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$3.6</td>
<td>$3.55</td>
<td>$3.6</td>
<td>$17.00</td>
<td>$57.9K</td>
<td>1.1K</td>
<td style="text-align: right;">286</td>
</tr>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$1.31</td>
<td>$1.29</td>
<td>$1.31</td>
<td>$15.00</td>
<td>$51.3K</td>
<td>4.8K</td>
<td style="text-align: right;">465</td>
</tr>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$0.94</td>
<td>$0.92</td>
<td>$0.92</td>
<td>$20.00</td>
<td>$46.0K</td>
<td>29.7K</td>
<td style="text-align: right;">721</td>
</tr>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$1.05</td>
<td>$1.03</td>
<td>$1.03</td>
<td>$15.00</td>
<td>$41.2K</td>
<td>26.6K</td>
<td style="text-align: right;">767</td>
</tr>
<tr>
<td>CCL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$2.47</td>
<td>$2.37</td>
<td>$2.47</td>
<td>$17.00</td>
<td>$37.5K</td>
<td>3.9K</td>
<td style="text-align: right;">16</td>
</tr>
</tbody>
</table>
</p>
<h3>About Carnival</h3>
<p>Carnival is the largest global cruise company, with 92 ships in service at the end of fiscal 2023. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&amp;O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe; and P&amp;O Cruises in Australia. Carnival also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted nearly 13 million guests in 2019, prior to covid-19, a level it reached again in 2023.</p>
<p>In light of the recent options history for Carnival, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Carnival's Current Market Status</h3>
<ul>
<li>With a volume of 14,396,886, the price of CCL is down -0.95% at $15.04. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 59 days.</li>
</ul>
<h3>Expert Opinions on Carnival</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $24.4.</p>
<ul>
<li>Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Carnival, targeting a price of $25. </li>
<li>Maintaining their stance, an analyst from Tigress Financial continues to hold a Buy rating for Carnival, targeting a price of $25. </li>
<li>Maintaining their stance, an analyst from JP Morgan continues to hold a Overweight rating for Carnival, targeting a price of $23. </li>
<li>An analyst from Macquarie persists with their Outperform rating on Carnival, maintaining a target price of $24. </li>
<li>Consistent in their evaluation, an analyst from Stifel keeps a Buy rating on Carnival with a target price of $25. </li>
</ul>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Carnival options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Behind the Scenes of Carnival's Latest Options Trends

<p>Financial giants have made a conspicuous bearish move on Ford Motor. Our analysis of options history for Ford Motor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) revealed 31 unusual trades.</p>
<p>Delving into the details, we found 48% of traders were bullish, while 51% showed bearish tendencies. Out of all the trades we spotted, 19 were puts, with a value of $2,250,293, and 12 were calls, valued at $651,468.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $7.82 to $17.82 for Ford Motor over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Ford Motor's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Ford Motor's whale trades within a strike price range from $7.82 to $17.82 in the last 30 days. </p>
<h3>Ford Motor Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714159889_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>F</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$0.46</td>
<td>$0.44</td>
<td>$0.46</td>
<td>$13.00</td>
<td>$427.8K</td>
<td>1.3K</td>
<td>2.0K</td>
</tr>
<tr>
<td>F</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$0.38</td>
<td>$0.37</td>
<td>$0.38</td>
<td>$12.82</td>
<td>$380.0K</td>
<td>19.8K</td>
<td>17.1K</td>
</tr>
<tr>
<td>F</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$0.57</td>
<td>$0.56</td>
<td>$0.57</td>
<td>$12.82</td>
<td>$218.9K</td>
<td>17.7K</td>
<td>6.5K</td>
</tr>
<tr>
<td>F</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$0.58</td>
<td>$0.56</td>
<td>$0.57</td>
<td>$12.82</td>
<td>$190.9K</td>
<td>17.7K</td>
<td>3.1K</td>
</tr>
<tr>
<td>F</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$0.51</td>
<td>$0.47</td>
<td>$0.5</td>
<td>$12.82</td>
<td>$136.2K</td>
<td>19.8K</td>
<td>4.2K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Ford Motor</h3>
<p>Ford Motor Co. manufactures automobiles under its Ford and Lincoln brands. In March 2022, the company announced that it will run its combustion engine business, Ford Blue, and its BEV business, Ford Model e, as separate businesses but still all under Ford Motor. The company has nearly 13% market share in the United States, about 11% share in the U.K., and under 2% share in China including unconsolidated affiliates. Sales in the U.S. made up about 66% of 2023 total company revenue. Ford has about 177,000 employees, including about 59,000 UAW employees, and is based in Dearborn, Michigan.</p>
<h3>Ford Motor's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 43,787,703, the F's price is down by -1.19%, now at $12.88. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 90 days.</li>
</ul>
<h3>What The Experts Say On Ford Motor</h3>
<p>In the last month, 3 experts released ratings on this stock with an average target price of $14.333333333333334.</p>
<ul>
<li>An analyst from RBC Capital has decided to maintain their Sector Perform rating on Ford Motor, which currently sits at a price target of $13. </li>
<li>An analyst from Barclays has decided to maintain their Overweight rating on Ford Motor, which currently sits at a price target of $16. </li>
<li>Consistent in their evaluation, an analyst from UBS keeps a Neutral rating on Ford Motor with a target price of $14. </li>
</ul>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Ford Motor with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Smart Money Is Betting Big In Ford Motor Options

<p>Financial giants have made a conspicuous bullish move on Zoetis. Our analysis of options history for Zoetis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZTS#NYSE">ZTS</a>) revealed 14 unusual trades.</p>
<p>Delving into the details, we found 57% of traders were bullish, while 35% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $216,721, and 11 were calls, valued at $668,978.</p>
<h3>Predicted Price Range</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $140.0 to $170.0 for Zoetis over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Zoetis's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Zoetis's substantial trades, within a strike price spectrum from $140.0 to $170.0 over the preceding 30 days.</p>
<h3>Zoetis Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714159884_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>ZTS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$4.8</td>
<td>$4.4</td>
<td>$4.4</td>
<td>$160.00</td>
<td>$220.0K</td>
<td>847</td>
<td style="text-align: right;">732</td>
</tr>
<tr>
<td>ZTS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$13.5</td>
<td>$10.9</td>
<td>$11.4</td>
<td>$165.00</td>
<td>$101.4K</td>
<td>169</td>
<td style="text-align: right;">90</td>
</tr>
<tr>
<td>ZTS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$3.4</td>
<td>$3.0</td>
<td>$3.2</td>
<td>$145.00</td>
<td>$83.5K</td>
<td>107</td>
<td style="text-align: right;">264</td>
</tr>
<tr>
<td>ZTS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$2.85</td>
<td>$2.8</td>
<td>$2.8</td>
<td>$165.00</td>
<td>$78.7K</td>
<td>1.1K</td>
<td style="text-align: right;">380</td>
</tr>
<tr>
<td>ZTS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$1.8</td>
<td>$1.6</td>
<td>$1.8</td>
<td>$170.00</td>
<td>$70.4K</td>
<td>833</td>
<td style="text-align: right;">431</td>
</tr>
</tbody>
</table>
</p>
<h3>About Zoetis</h3>
<p>Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.</p>
<p>Having examined the options trading patterns of Zoetis, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Zoetis's Current Market Status</h3>
<ul>
<li>Trading volume stands at 3,082,324, with ZTS's price up by 3.33%, positioned at $158.46.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 6 days.</li>
</ul>
<h3>What Analysts Are Saying About Zoetis</h3>
<p>In the last month, 3 experts released ratings on this stock with an average target price of $206.66666666666666.</p>
<ul>
<li>Consistent in their evaluation, an analyst from Stifel keeps a Buy rating on Zoetis with a target price of $195. </li>
<li>An analyst from Piper Sandler has revised its rating downward to Overweight, adjusting the price target to $195. </li>
<li>Maintaining their stance, an analyst from Barclays continues to hold a Overweight rating for Zoetis, targeting a price of $230. </li>
</ul>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Zoetis with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


Behind the Scenes of Zoetis's Latest Options Trends

<p>Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) has outperformed the market over the past 15 years by 4.63% on an annualized basis producing an average annual return of 16.81%. Currently, Blackstone has a market capitalization of $92.87 billion. </p>
<p><strong>Buying $1000 In BX:</strong> If an investor had bought $1000 of BX stock 15 years ago, it would be worth <strong>$10,844.86</strong> today based on a price of $122.33 for BX at the time of writing.</p>
<h3>Blackstone's Performance Over Last 15 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714159824_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


$1000 Invested In Blackstone 15 Years Ago Would Be Worth This Much Today

<p>Monolithic Power Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MPWR#NASDAQ">MPWR</a>) has outperformed the market over the past 5 years by 22.56% on an annualized basis producing an average annual return of 34.17%. Currently, Monolithic Power Systems has a market capitalization of $32.13 billion. </p>
<p><strong>Buying $1000 In MPWR:</strong> If an investor had bought $1000 of MPWR stock 5 years ago, it would be worth <strong>$4,390.86</strong> today based on a price of $660.34 for MPWR at the time of writing.</p>
<h3>Monolithic Power Systems's Performance Over Last 5 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1714159818_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


MPWR

Here's How Much You Would Have Made Owning Monolithic Power Systems Stock In The Last 5 Years

Legal

White House Says No Timeline For How Long Menthol Decision Delayed

<p>In the midst of the meme coin super cycle frenzy, swing trader <strong>Picolas Cage</strong> has taken a stand against meme coins, arguing that they are harmful to the <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38467743/arthur-hayes-bitcoin-bull-market-not-over-urges-investors-to-left-curve-it">overall cryptocurrency ecosystem</a>.</p>
<p><strong>What Happened:</strong> "They are disinteresting from a technical perspective and don&#8217;t offer anything other than a pure ponzi," the trader writes, emphasizing their lack of substance.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">IMO memecoins are destroying crypto.<br /><br />I still maintain the opinion that memecoins are a net negative to this space.<br /><br />They are disinteresting from a technical perspective and don&#39;t offer anything other than a pure ponzi.<br /><br />They are predatory in nature and usually create a market…</p>
<p>&mdash; Picolas Cage (@Picolas_Caged) <a href="https://twitter.com/Picolas_Caged/status/1783460696174285006?ref_src=twsrc%5Etfw">April 25, 2024</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p>He criticized their predatory nature, suggesting that they create an unfair market environment where less informed participants are pitted against more knowledgeable traders.</p>
<p><strong>What's The Process:</strong> According to Picolas Cage, savvy traders exploit meme coins by accumulating large positions through liquidity pools and MEV bots without significantly impacting prices. They then promote these meme coins to their followers, creating artificial demand and enticing less experienced investors to buy in.</p>
<p>This process, he argues, perpetuates a &#8220;Player vs Player&#8221; dynamic masquerading as &#8220;Player vs Environment,&#8221; where large accounts sell off their holdings to unsuspecting individuals hoping for massive returns.</p>
<p>He also notes that meme coins divert attention away from genuine technological innovations and potential wealth-generation opportunities in the broader crypto market.</p>
<p><figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure></p>
<p><em>Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38460505/are-dogecoin-and-shiba-inu-primed-for-the-next-leg-up">Are Dogecoin And Shiba Inu Primed For The Next Leg Up?</a></em></p>
<p><strong>Why It Matters: </strong>Cage traces the bullish phase of meme coins back to <strong>Dogecoin's</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) previous pump cycle, fueled by &#8220;normies&#8221; using profits from <strong>GameStop</strong> stock investments to enter the crypto market and show &#8220;crypto bros&#8221; the proverbial middle finger. This, however, contrasts with the new generation of meme coins that Cage sees as purely extractive.</p>
<p>In conclusion, Picolas Cage&#8217;s critique raises important questions about the impact of meme coins on the crypto market and the risks they pose to uninformed investors.</p>
<p><strong>What's Next</strong>: The influence of meme coins and&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;are topics expected to be thoroughly explored at Benzinga's upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.</p>
<p><em>Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38454567/trader-who-turned-15k-into-5m-predicts-these-4-meme-coins-to-emulate-the-success-of-doge-s">Trader Who Turned $15K Into $5M Predicts These 4 Meme Coins To Emulate The Success Of DOGE, SHIB, FLOKI</a></em></p>
<p><em>This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.</em></p>
<p><em>Image: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

Meme Coins Are 'A Pure Ponzi' And 'Destroying Crypto,' Says Trader Who Thinks Dogecoin Was Different

iShares MSCI Hong Kong Index Fund is trading higher amid strength in Chinese stocks.

<p><strong>ImmunityBio, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) shares are trading higher Friday after the company announced overall survival results<a href="https://www.benzinga.com/news/24/04/38424671/why-teradyne-shares-are-trading-higher-by-over-8-here-are-20-stocks-moving-premarket"> in its QUILT 3.055 study.</a></p>
<p><strong>The Details:</strong></p>
<p>ImmunityBio said the QUILT 3.055 trial <a href="https://www.benzinga.com/pressreleases/24/04/b38421500/immunitybio-announces-positive-overall-survival-results-of-anktiva-combined-with-checkpoint-inhibi">shows</a> median overall survival almost double that of standard of care chemotherapy in 2nd- and 3rd-line non-small cell lung cancer (NSCLC) patients whose cancer did not respond to checkpoint inhibitors with or without chemotherapy. </p>
<p>"The results we noted with the completion of the QUILT 3.055 basket trial across multiple tumor types in patients with late-stage cancers for whom standard of care plus checkpoints failed, validates our hypothesis that orchestration of NK cells with killer T cells and memory T cells could result in meaningful clinical improvements to current standards of care," said Patrick Soon-Shiong, M.D., CSO of ImmunityBio.&nbsp;</p>
<p>The FDA <a href="https://www.benzinga.com/general/biotech/24/04/38380405/fda-approves-immunitybios-bladder-cancer-drug-stock-rallies">approved</a> the company's Anktiva plus Bacillus Calmette-Guérin (BCG) for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) on Monday.&nbsp;</p>
<p>ImmunityBio shares are moving on heavy trading volume Friday. According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, more than 26.6 million shares have been traded in the session, compared to the stock&#8217;s 100-day average of 4.774 million shares.</p>
<p><em>Related News: </em><a href="https://www.benzinga.com/news/24/04/38360358/whats-going-on-with-luxury-ev-maker-lucids-stock"><em>What&#8217;s Going On With Luxury EV-Maker Lucid&#8217;s Stock?</em></a></p>
<h2 class="wp-block-heading">How To Buy IBRX Stock: </h2>
<p>By now you're likely curious about how to participate in the market for ImmunityBio &#8211; be it to purchase shares, or even attempt to bet against the company.</p>
<p>Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so. </p>
<p>If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.</p>
<p><strong>IBRX Price Action:</strong> According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, ImmunityBio shares are up 48% at $7.56 at the time of publication Friday.</p>
<p><em>Image: Akava Photo</em> <em>from Pixabay</em></p>
